Umoja Biopharma Funding: $153M Raised, Series C (2025)
Umoja Biopharma is a Biotech company based in Seattle. It has raised $153M in total funding. Latest round: Series C.
Umoja Biopharma funding overview
Umoja Biopharma is a Biotech company based in Seattle. Umoja Biopharma has raised $153M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series C announced in January 2025. The round record for Umoja Biopharma runs through 2025; nothing later has been disclosed. Investors on record include MPM Capital, DCVC Bio, Qiming Venture Partners USA. 3 distinct backers are named across the disclosed rounds.
Umoja Biopharma at a glance
Total raised
$153M
Latest round
Series C
Latest round date
January 2025
Industry
Biotech
Headquarters
Seattle
Notable investors
MPM Capital, DCVC Bio, Qiming Venture Partners USA
Frequently asked about Umoja Biopharma funding
How much has Umoja Biopharma raised?
Umoja Biopharma has raised $153M in total disclosed funding across the rounds on record.
Who has invested in Umoja Biopharma?
MPM Capital, DCVC Bio, Qiming Venture Partners USA are named among the investors backing Umoja Biopharma.
What was the latest Umoja Biopharma funding round?
The most recent disclosed round is a Series C, announced in January 2025.
Where is Umoja Biopharma based?
Umoja Biopharma is based in Seattle.
What sector does Umoja Biopharma operate in?
Umoja Biopharma is tracked under Biotech from Seattle, with $153M in disclosed funding.
When did Umoja Biopharma last raise?
The last disclosed Umoja Biopharma round closed in January 2025 at Series C.
Round data for Umoja Biopharma is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the Biotech companies in Seattle and backer lists below.
